Product NDC: | 63629-3982 |
Proprietary Name: | VALTREX |
Non Proprietary Name: | valacyclovir hydrochloride |
Active Ingredient(s): | 1 g/1 & nbsp; valacyclovir hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, FILM COATED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 63629-3982 |
Labeler Name: | Bryant Ranch Prepack |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA020487 |
Marketing Category: | NDA |
Start Marketing Date: | 20020812 |
Package NDC: | 63629-3982-1 |
Package Description: | 7 TABLET, FILM COATED in 1 BOTTLE (63629-3982-1) |
NDC Code | 63629-3982-1 |
Proprietary Name | VALTREX |
Package Description | 7 TABLET, FILM COATED in 1 BOTTLE (63629-3982-1) |
Product NDC | 63629-3982 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | valacyclovir hydrochloride |
Dosage Form Name | TABLET, FILM COATED |
Route Name | ORAL |
Start Marketing Date | 20020812 |
Marketing Category Name | NDA |
Labeler Name | Bryant Ranch Prepack |
Substance Name | VALACYCLOVIR HYDROCHLORIDE |
Strength Number | 1 |
Strength Unit | g/1 |
Pharmaceutical Classes | DNA Polymerase Inhibitors [MoA],Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient] |